West Virginia University Logo

May 7, 2015

PAW Weekly Update

SAMHSA Prescription Drug Abuse Weekly Update
Issue 121  |  May 7, 2015
The Prevention of Prescription Drug Abuse in the Workplace (PAW) TA Center addresses prescription drug abuse—a growing public health problem with increasing burdens on workers, workplaces, and our economy. To subscribe colleagues, family members, or friends to this listserv sponsored by the Substance Abuse and Mental Health Services Administration (SAMHSA), please click here or send their e-mail addresses to paw@dsgonline.com.
Table of Content Featured Article Journal Articles and Reports Professional Education National News Medical Marijuana International Northeast/Mid-Atlantic News Midwest News West News Upcoming Webinars Grant Announcements Take-Back Events and Drop Boxes Upcoming Conferences and Workshops

Webinars: Register Now!

Responding to the Prescription Misuse Epidemic: Promising Prevention Programs and Useful Resources
Substance Abuse and Mental Health Services Administration
May 20, 2015, 2 p.m. EDT


Implementing Project Lazarus in North Carolina: Lessons Learned from the Hub Components of the Project Lazarus Model
Children's Safety Network
May 11, 2015, 2–3:30 p.m. (EDT)

This Webinar will illustrate key issues and challenges related to implementation of Project Lazarus as a model prescription drug overdose prevention program. The Webinar will highlight lessons learned in both the hub activities (components that reflect a community-based, bottom-up public health approach) and spoke activities (components that reflect a medical and law enforcement–based, top-down public health approach).



Prescription Drug Deaths in Texas Vastly Undercounted
Lise Olsen and Mary Ann Roser, Houston Chronicle
April 25, 2015

Last summer, the commissioner of the Texas Department of State Health Services testified that Texas has one of the nation's lowest prescription drug fatality rates and that deaths peaked in 2006. In reality, although state death certificate data attributed only 622 deaths statewide to opioids in 2013, a Centers for Disease Control and Prevention special study estimated there were 980 prescription drug–related deaths that year in Texas, and another 1,215 overdose deaths without data on the specific drugs involved. The Houston Chronicle and Austin American-Statesman found Texas undercounted fatalities from prescription drugs in every major county. Medical examiners in just 17 of the state's 254 counties recorded 798 prescription drug–related deaths in 2013. The state reported 179 deaths from pain relievers in Harris County, Houston, while the county medical examiner's office reported 275 deaths involving all prescription drugs. In Travis County, Austin, the state reported 17 deaths from prescription pain relievers, but the county medical examiner's office hand-counted 114 deaths linked to prescription drugs. In Tarrant County, Fort Worth, the medical examiner's office recorded 44 deaths involving specific prescription drugs and another 57 fatalities from mixed drugs; the state's count was 24 opioid overdoses. In much of Texas, cause of death is determined by 860 elected justices of the peace (all of whom are attorneys) as opposed to medical examiners. A late-stage cancer patient who took too many prescription drugs could be classified as having died of natural causes by one justice or from a prescription drug overdose by another, said Janice Sons, president of the Justices of the Peace and Constables Association of Texas. Bexar County, San Antonio, does not separate prescription pain reliever deaths from heroin deaths. Counties with tight budgets also limit postmortem drug testing. Worse, death certificates completed before toxicology results are received are often not updated. The federal government normally relies on state cause-of-death data without checking data from the country's 2,300 medical examiners, justices of the peace, and coroners. A voluntary federal medical examiners reporting program was discontinued in 2010.

Read more:

Partnership for Drug-Free Kids. 2015. Report: Prescribers, Patients and Pain.

In new nationally representative surveys, 77 percent of prescribers said they are primarily responsible for providing information about the potential to become addicted to or dependent on opiates. Two thirds of primary care physicians and half of pain management specialists said they "always" give information on the potential for addiction and dependency. Consistent with those reports, 81 percent of chronic pain patients and 60 percent of acute pain patients said someone had warned them of the potential for becoming dependent on or addicted to prescription pain relievers. Almost 40 percent of chronic pain patients and 30 percent of acute pain patients are concerned with becoming addicted to their pain medications. Thirty-eight percent of chronic pain patients and 43 percent of acute pain patients feel uncomfortable taking their prescribed opiates. Seven percent of chronic pain patients and 13 percent of acute pain patients report misusing their opiate prescriptions, and 13 percent of chronic pain patients and 15 percent of acute pain patients admit to taking someone else's opiates. Four out of five heroin users started abusing prescription opiates by misusing or abusing prescription medication.

Read more:

Journal Articles and Reports

C. Conrad, H.M. Bradley, D. Broz, S. Buddha, E.L. Chapman, R.R. Galang, D. Hillman, J. Hon, K.W. Hoover, M.R. Patel, A. Perez, P.J. Peters, P. Pontones, J.C. Roseberry, M. Sandoval, J. Shields, J. Walthall, D. Waterhouse, P.J. Weidle, H. Wu, and J.M. Duwve. 2015. "Community Outbreak of HIV Infection Linked to Injection Drug Use of Oxymorphone—Indiana, 2015." Morbidity and Mortality Weekly Report 64(16):443–44.

The Indiana State Department of Health has diagnosed 135 cases of HIV in a community of 4,200. Seventeen contacts have declined testing, 121 were HIV-negative, and 128 have not yet been located, including 74 syringe-sharing or sex partners. Of 112 people interviewed, 108 reported injection drug use. Co-infection with hepatitis C virus has been diagnosed in 114 people. Ten of the individuals infected were sex workers. Last week's national news previewed parts of this study.

Read more:

G. D'Onofrio, P.G. O'Connor, M.V. Pantalon, M.C. Chawarski, S.H. Busch, P.H. Owens, S.L. Bernstein, and D.A. Fiellin. 2015. "Emergency Department–Initiated Buprenorphine/Naloxone Treatment for Opioid Dependence." JAMA 313(16):1636–644, doi:10.1001/jama.2015.3474.

A clinical trial at a Yale University emergency department randomized 329 opioid-dependent patients during 2009–13 to a referral group, a brief intervention group, or a buprenorphine treatment group. Seventy-eight percent of patients in the buprenorphine group versus 37 percent in the referral group and 45 percent in the brief intervention group were in addiction treatment on day 30 following randomization. The buprenorphine group reduced the number of days of illicit opioid use per week from 5.4 to 0.9 versus a reduction from 5.4 to 2.3 in the referral group and 5.6 to 2.4 in the brief intervention group. Eleven percent of patients in the buprenorphine group used inpatient addiction treatment services compared with 37 percent in the referral group and 35 percent in the brief intervention group. This is the third unsuccessful brief intervention trial for drug use disorders reported this year.

Read more:

D.G. Duryea, N.G. Calleja, and D.A. MacDonald. 2015. "Nonmedical Use of Prescription Drugs by College Students with Minority Sexual Orientations." Journal of College Student Psychotherapy 29(2):147–59, doi:10.1080/87568225.2015.1008374.

In the 2009 National College Health Assessment, male and female students who self-identified as gay or bisexual were significantly more likely to use nonmedical prescription drugs and illicit drugs than heterosexual students.

Read more:

E.V. Nunes, E. Krupitsky, W. Ling, J. Zummo, A. Memisoglu, B.L. Silverman, and D.R. Gastfriend. 2015. "Treating Opioid Dependence with Injectable Extended-Release Naltrexone (XR-NTX): Who Will Respond?" Journal of Addiction Medicine, doi:10.1097/ADM.0000000000000125.

Moderator analysis on a previously reported 24-week, placebo-controlled randomized controlled trial of extended-release naltrexone versus placebo among 126 recently detoxified opioid-dependent adults in Russia examined an indicator of good clinical response—at least 90 percent abstinence over the 24-week trial. A higher Clinical Global Impression-Severity score was associated with a lower rate of good clinical response.

Read more:

V.N. Tolia, S.W. Patrick, M.M. Bennett, K. Murthy, J. Sousa, P.B. Smith, R.H. Clark, and A.R. Spitzer. 2015. "Increasing Incidence of the Neonatal Abstinence Syndrome in U.S. Neonatal ICUs." The New England Journal of Medicine, doi:10.1056/NEJMsa1500439.

Researchers analyzed 2004–13 neonatal abstinence syndrome (NAS) data from 299 U.S. neonatal intensive care units (NICUs). Of 674,845 infant admissions, 10,327 were diagnosed with NAS. The NAS admission rate increased from 7 cases per 1,000 admissions to 27 cases per 1,000 admissions; median length of stay for NAS infants increased from 13 days to 19 days. The percentage of NICU days nationwide attributed to NAS increased from 0.6 percent to 4.0 percent. Infants increasingly received pharmacotherapy (74 percent in 2004 versus 87 percent in 2012–13), with morphine used for 49 percent in 2004 versus 72 percent in 2013.

Read more:

K.M. Wawrzyniak, A. Sabo, A. McDonald, J.J. Trudeau, M. Poulose, M. Brown, and N.P. Katz. 2015. "Root Cause Analysis of Prescription Opioid Overdoses." Journal of Opioid Management 11(2):127–37, doi:10.5055/jom.2015.0262.

This small study involved interviews with 10 survivors of prescription opioid overdoses and 5 family members. Proximal causes of overdose were recent prescription dose escalation (n = 9), polysubstance use (n = 5), and polypharmacy use (n = 3). Antecedent causes were wanting to feel good/high (n = 9), perceived tolerance to prescription opioid overdose (n = 6), not knowing/believing it was dangerous (n = 5), wanting to reduce psychosocial pain (n = 5), wanting to reduce physical pain (n = 4), and wanting to avoid discomfort due to withdrawal symptoms (n = 4). Overdoses involved drugs prescribed by a doctor (n = 7), purchased from a dealer (n = 6), given/purchased from family/friends (n = 3), or stolen from family (n = 1). Psychosocial stressors (n = 9), chronic recurrent depression (n = 3), and chronic substance abuse/addiction (n = 4) were distal or proximal causes of overdose. Three experts cited similar causes but added inadequate prescriber training and healthcare system and culture.

Read more:


A. Golub, A.S. Bennett, and L. Elliott. 2015. "Beyond America's War on Drugs: Developing Public Policy to Navigate the Prevailing Pharmacological Revolution." AMS Public Health 2(1):142–60, doi:10.3934/publichealth.2015.1.142.

This brief history of America's experience with substance use and substance use policy over the past several hundred years provides background and a framework to compare the current Pharmacological Revolution with America's nineteenth century Industrial Revolution. The paper cautions about growing challenges and makes suggestions for navigating this revolution and reducing its negative impact on individuals and society.

Read more:

C.K.M.W. Schauer, J.A.D. Shand, and T.M. Reynolds. 2015. "The Fentanyl Patch Boil-Up—A Novel Method of Opioid Abuse." Basic and Clinical Pharmacology and Toxicology, doi:10.1111/bcpt.12412.

Researchers presented a case of intravenous fentanyl abuse after extraction from a Mylan (matrix type) patch. This method of abuse has not been previously described in the literature.

Read more:


Donnelly, Ayotte File Bill to Fight Opioid Abuse
Brian Francisco, The Journal Gazette
April 29, 2015

Indiana Senators Donnelly and Ayotte reintroduced legislation aimed at reducing heroin and pain medication dependency through improved prescription practices, increased law enforcement, greater public awareness, and expanded first responders' access to and administration of naloxone. The Donnelly–Ayotte bill would also create the Interagency Task Force on Prescribing Practices to develop best practices for prescribing pain relievers and related pain management.

Read more:


ACLU Rhode Island Medical Marijuana Lawsuit Highlights Hazy Hiring Practices in Era of Legal Weed
Philip Ross, International Business Times
April 28, 2015

The Rhode Island Chapter of the American Civil Liberties Union plans to file a complaint against an employer who refuses to hire medical marijuana patients. State law bars employers from refusing to "employ … a person solely for his or her status as a [medical marijuana] cardholder." At the same time, the law does not compel an employer "to accommodate the medical use of marijuana in any workplace." In the past, an appellate court sided with the employer, saying Rhode Island companies could lawfully fire workers for failing drug tests. Neither the employer nor the plaintiff has been named in the complaint.

Read more:

Sask. Man Forced off Medicinal Marijuana by Employer
Francois Biber, CJME
April 24, 2015

Mr. Jarett, a man living in Saskatchewan, Canada, filed a complaint against his employer for violating his human rights to use medical marijuana. After Jarett disclosed his prescription to his employer, he was told to stop using medicinal marijuana or forfeit his job. Marijuana was considered a prohibited substance and went against the company's drug and impairment policy. The company's nurses and lawyer told Jarett he could not come to work with traces of THC (50 nanograms) in his blood. Jarett said he used the drug at home after work. He stopped taking medical marijuana and is back at the company, but suffers from headaches because nothing besides medicinal marijuana has helped relieve his pain.

Read more:

Spice Problem Labeled as Local 'Epidemic'
Emily Devoe
April 28, 2015

Local officials said the spice problem in Mobile, Ala., is now an epidemic. Melissa Costello, director of emergency medicine at Mobile Infirmary, said the department has up to 20 synthetic marijuana (spice) cases per day. Hospitals throughout the state reported more than 400 patients with symptoms linked to synthetic marijuana between March 15 and April 20. The drug is coming from China and the Mobile area. (Includes video: 2:37 minutes)

Read more:

Legislation Allowing Marijuana Use for Medical Purposes Clears Senate Panel
Elizabeth Crisp, The Advocate
April 30, 2015

The Louisiana Senate Health and Welfare Committee approved Senate Bill 143, which would direct the Louisiana Board of Pharmacy to adopt rules regulating production and dispensing of prescribed marijuana by December 2016. The bill now heads to the full Senate for consideration.

Read more:

Canada's Health Minister Says Dispensaries Normalize Marijuana Use
CBC News
April 25, 2015

The federal government wants Vancouver to shut down local marijuana dispensaries. On the Coast interviews Federal Health Minister Rona Ambrose about medical marijuana and Vancouver's plan to regulate marijuana dispensaries instead. (Includes audio: 10:17 minutes)

Read more:


The Government of Canada Encourages Canadians to Join the Efforts to Prevent Prescription Drug Abuse
April 30, 2015

The Minister of Health and Minister of Public Safety and Emergency Preparedness urged all Canadians to participate in National Prescription Drug Drop-Off Day on May 9. The Canadian Association of Chiefs of Police will coordinate the event.

Read more:

Northeast/Mid-Atlantic News

Christie Signs Bills to Fight Substance Abuse
Matt Arco, NJ Advance
April 30, 2015

Governor Chris Christie signed two bills to expand the state's medicine drop-off program and another to establish a statewide Opioid Law Enforcement Task Force. The task force will identify, investigate, and prosecute illegal sources and distribution of opiate drugs.

Read more:

Lawmakers Plan Stockpiles of Overdose-Reversing Drug
Christian M. Wade, Eagle-Tribune
April 29, 2015

Massachusetts State Attorney General Maura Healey says since June 2014, naloxone's cost has increased from $19.56 to $41.43 for a 2-milliliter dose. Last week, she launched an investigation into the price hikes. State Representative Linda Campbell is among almost 30 backers of a proposed amendment to the state budget bill that would allow the Massachusetts Department of Public Health and Executive Office of Public Safety and Security to stockpile bulk-purchased naloxone and resell the drug to police departments at cost.

Read more:

State: More Than 1,000 Died of Opioid-Related Overdoses in 2014
Benjamin Swasey, WBUR
April 29, 2015

In Massachusetts, more than 1,000 people died from opioid-related overdoses last year—a 33 percent increase from 2012, but virtually unchanged from 2013. In 2014, Middlesex County had the most opioid overdose deaths (212), followed by Essex (146), Bristol (117), and Worcester (113) counties. Nantucket County had just one death. (Includes audio: 3:19 minutes)

Read more:

Massachusetts Not Seeing Spike in HIV Cases, Despite CDC Alert over Shared Drug Needles
Anne–Gerard Flynn, MassLive
April 27, 2015

The Massachusetts Department of Health and Human Services has not seen more people infected with the HIV or hepatitis C virus. In recent years, the HIV infection rate among injection drug users has declined in Massachusetts.

Read more:

Drug Overdose Antidote Available to Anyone in Westmoreland County
Ashlie Hardway, WTAE-TV
April 27, 2015

Westmoreland County, Pa., residents can now purchase naloxone from the Medicine Shoppe in Latrobe and Salem Crossroads Pharmacy in Delmont. Residents can also attend training classes on the drug. (Includes video: 2:02 minutes)

Read more:

Partnership for Drug-Free Kids Brings Life-Saving Kits and Training to New Jersey Families
The Partnership for Drug-Free Kids
April 27, 2015

Along with the Partnership for Drug-Free Kids, the Community Coalition for a Safe and Healthy Morris (New Jersey) and its parent partners began offering training and free naloxone kits to family members of prescription opiate users.

Read more:

Midwest News

Data Show Big Drop in Hennepin County Opiate Deaths
Jon Collins, MPR News
April 27, 2015

Deaths tied to heroin or prescription opiates in Hennepin County, Minn., fell from 132 in 2013 to 102 in 2014, while they increased slightly in Ramsey County. Officials attributed the decrease to the county's efforts to expand naloxone use.

Read more:

Heroin Feeds Record Number of Ohio Drug Deaths
Alan Johnson and Catherine Candisky, The Columbus Dispatch
May 1, 2015

In 2013, drugs took the lives of 2,110 people in Ohio—a record high—up from 1,914 deaths in 2012. Prescription drug deaths increased from 680 to 726. Black tar heroin from coastal Mexico contributed to 983 overdose deaths—a 41 percent increase from the previous year. The state's highest age-adjusted overdose death rates were in Brown County (32.5 per 100,000) and Scioto County (29.3 per 100,000).

Read more:

Painkiller Fentanyl Holds Dangerous Allure for Addicts
Jim Woods, The Columbus Dispatch
April 27, 2015

After overdosing on fentanyl or fentanyl combined with another drug, 15 people died in Franklin County, Ohio, during the first 3 months of 2015—up from 19 last year. The Fairfield County coroner also noticed an uptick in fentanyl-related deaths, but the Delaware, Madison, Pickaway, and Union county coroners' offices have not seen any fentanyl-related deaths this year.

Read more:

West News

Nevada First Lady Testifies in Favor of Prescription Monitoring Bill
Steven Moore, Las Vegas Review-Journal
April 29, 2015

Nevada first lady Kathleen Sandoval testified in favor of Senate Bill 459, which would require all practitioners to check the state's prescription drug monitoring program (PDMP) before ordering certain controlled substances. Sandoval's cousin died from a heroin overdose that started with prescription drug misuse. The bill would also grant immunity for doctors administering medications to reverse the effects of an opioid overdose. Only an estimated 50 percent of Nevada physicians have registered to use the PDMP database.

Read more:

State Looking for Comments on New Opioid Drug Rules
Brooks Johnson, Longview Daily News
April 16, 2015

The Washington Agency Medical Directors requested comments on new prescription guidelines for opioid pain relievers. These guidelines offer expanded advice for different populations of patients and phases of pain.

Read more:

Cottonwood Heights Mayor Defends Police Search of Drug Database
Dennis Romboy, KSL
April 25, 2015

Cottonwood Heights Mayor Kelvyn Cullimore defended his police department's search of the Utah prescription drug monitoring program (PDMP) database, which led to criminal charges against United Fire Authority Assistant Chief Marlon Jones and paramedic Ryan Pyle. State prosecutors dropped the charges against both men about 18 months later. Now, Jones and Pyle have filed separate federal lawsuits against the city, claiming Cottonwood Heights police violated their privacy when a detective obtained their medical histories through the database without probable cause or a search warrant. Cullimore said the detective did not do anything illegal or violate medical confidentiality laws. The law changed earlier this year to require law enforcement to obtain a search warrant with a specific name attached before accessing PDMP data.

Read more:

Life-Saving Drug Reverses the Effects of Prescription Drug Overdoses
Lacy Lett, KFOR
April 24, 2015

Pottawatomie County, Okla., police officers attended a training to learn how to administer naloxone. The Tulsa Police Department started using the drug 1 year ago and has already revived 15 people. (Includes video: 1:39 minutes)

Read more:

Cheyenne Regional to Combat Drug Abuse in E.R.
Miles Bryan, Wyoming Public Media
April 27, 2015

In April, Cheyenne Regional Medical Center launched a crackdown on prescription drug abuse in the emergency room. Now, a board of doctors and administrators meets monthly to decide if a patient's emergency room behavior constitutes misuse. The hospital sends problem patients a certified letter telling them they will not get prescription pain relievers for anything other than a dire emergency. The patient's primary care doctor also gets a letter. Fifteen patients received letters from the hospital after the first board meeting.

Read more:

Sheriff's Office No Longer Accepting Rx Drugs, Landfill Next Option
Nick Rothschild, KJCT 8
April 27, 2015

The Mesa County Sheriff's Office in Colorado is no longer accepting unwanted, expired, or unused prescription drugs. Residents should take them to the Mesa County Hazardous Waste Facility in Grand Junction.

Read more:

Upcoming Webinars

Nevada's Prescription Monitoring Program (PMP): Clinical Utility of Patient and Prescriber Reports
University of Nevada School of Medicine
May 13, 2015, 12–1 p.m.


Grant Announcements

Rural Opioid Overdose Reversal Grant Program
Department of Health and Human Services, Health Resources and Services Administration
Deadline: June 8, 2015

The goals of this funding announcement are to 1) purchase naloxone and opioid overdose reversal devices and increase availability in rural areas through strategic placement; 2) train licensed healthcare professionals and others using the devices to recognize signs of opioid overdose, administer naloxone, administer basic cardiopulmonary life support, report results, and provide appropriate transport to a hospital or clinic for continued care after administration; 3) refer those with a drug dependency to appropriate substance abuse treatment centers where care coordination is provided by a team of providers; and 4) demonstrate improved and measurable health outcomes, including reducing opioid overdose morbidity and mortality in rural areas.

Read more:

Edward Byrne Memorial Justice Assistance Grant (JAG) Program
Department of Justice, Bureau of Justice Assistance
Deadline: June 16, 2015

The JAG program provides states and local governments with funding support for law enforcement, prosecution and court programs, prevention and education programs, corrections and community corrections, drug treatment and enforcement, crime victim and witness initiatives, and planning, evaluation, and technology improvement.

Read more:

Harold Rogers Prescription Drug Monitoring Program FY 2015
United States Department of Justice
Deadline: May 28, 2015

Take-Back Events and Drop Boxes

Maine Takes Back 24,000 Pounds of Unused Prescription Drugs
The News Tribune (Washington)
April 26, 2015

Prescription Drug Round Up Collects More Than 2,100 Pounds
Pat Thomas, KOLO (Nevada)
April 28, 2015

Loudoun 'Take-Back' Day Nets 1,160 Pounds of Unused Prescription Drugs
Chris Gaudet, Leesburg Patch (Virginia)
April 27, 2015

483 Lbs. of Prescription Drugs Collected in Take Back
Nexstar Broadcasting (Arkansas)
April 30, 2015

Police: Prescription Drug Take Back Event Breaks Records
Saline247.com (Arkansas)
April 27, 2015

Gundersen Prescription Drop Boxes Head Toward a Ton of Drugs
Mike Tighe, LaCrosse Tribune (Wisconsin)
April 28, 2015

Lucas County's Drug Collection Day a Success
Alexandra Mester, The Blade (Ohio)
April 26, 2015

Lancaster Community Helps Prevent Prescription Drug Abuse Through Proper Disposal
Logan Daily (Ohio)
April 25, 2015

Prescription Drug Drop-Off Day May 9, 2015
District of Oak Bay (British Columbia, Canada)
April 28, 2015

Prescription Drug Drop Off
Niagara Regional Police Service (Ontario, Canada)
Accessed April 29, 2015

Harvard Provides Place to Safely Dispose of Drugs
Northwest Herald (Illinois)
April 26, 2015

Permanent Location for Prescription Drug Drop-Off in Belvidere
WIFR (Illinois)
April 27, 2015

Drug Disposal Available in Nebraska City
Nebraska City News-Press (Nebraska)
April 29, 2015

Prescription Drug Drop Off Held at Millard Fillmore Suburban Hospital
The Warner Cable News (New York)
April 25, 2015

Drug Drop Box Installed at Cranston Police Department
Tracee M. Herbaugh, Providence Journal (Rhode Island)
April 28, 2015

Altoona Awarded Drug Collection Unit
Emily Van Ort, WQOW (Wisconsin)
April 27, 2015

Prescription Drug Take Back in Wheeling
WTOV (West Virginia)
April 26, 2015

Upcoming Conferences and Workshops

Pharmacy Diversion Awareness Conferences
Drug Enforcement Administration, Office of Diversion Control
May 30–31, 2015: Norfolk, Virginia
June 27–28, 2015: Oklahoma City, Oklahoma

International Conference on Opioids
Harvard Medical School
June 7–9, 2015
Boston, Massachusetts


Fourth Annual Generation Rx University Conference for Collegiate Prevention and Recovery
The Ohio State University College of Pharmacy
August 4–6, 2015
Columbus, Ohio


The Weekly Update is a service provided by the SAMHSA Preventing Prescription Abuse in the Workplace Technical Assistance Center (PAW) to keep the field abreast of recent news and journal articles to assist in forming policy, research, and programs to reduce prescription drug misuse or abuse. Please note, the materials listed are not reflective of SAMHSA's or PAW's viewpoint or opinion and are not assessed for validity, reliability or quality. The Weekly Update should not be considered an endorsement of the findings. Readers are cautioned not to act on the results of single studies, but rather to seek bodies of evidence. Copyright considerations prevent PAW from providing full text of journal articles listed in the Weekly Update.